These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37923671)

  • 41. Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors.
    Weich A; Serfling SE; Schlötelburg W; Higuchi T; Hartrampf PE; Schirbel A; Heinrich M; Buck AK; Rowe SP; Kosmala A; Werner RA
    Clin Nucl Med; 2023 Jul; 48(7):586-593. PubMed ID: 37167408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Rapid and Specific HPLC Method to Determine Chemical and Radiochemical Purity of [
    Migliari S; Sammartano A; Scarlattei M; Baldari G; Silva C; Ruffini L
    Curr Radiopharm; 2021; 14(2):121-130. PubMed ID: 32990551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the performance of
    Yin X; Ai K; Luo J; Liu W; Ma X; Zhou L; Xiang X; Su X; Wang Y; Li Y
    Front Endocrinol (Lausanne); 2024; 15():1291775. PubMed ID: 38419957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
    Vag T; Gerngross C; Herhaus P; Eiber M; Philipp-Abbrederis K; Graner FP; Ettl J; Keller U; Wester HJ; Schwaiger M
    J Nucl Med; 2016 May; 57(5):741-6. PubMed ID: 26769866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemokine receptor - Directed imaging and therapy.
    Buck AK; Stolzenburg A; Hänscheid H; Schirbel A; Lückerath K; Schottelius M; Wester HJ; Lapa C
    Methods; 2017 Nov; 130():63-71. PubMed ID: 28916148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [
    Derlin T; Sedding DG; Dutzmann J; Haghikia A; König T; Napp LC; Schütze C; Owsianski-Hille N; Wester HJ; Kropf S; Thackeray JT; Bankstahl JP; Geworski L; Ross TL; Bauersachs J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1934-1944. PubMed ID: 29967943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.
    Wester HJ; Keller U; Schottelius M; Beer A; Philipp-Abbrederis K; Hoffmann F; Šimeček J; Gerngross C; Lassmann M; Herrmann K; Pellegata N; Rudelius M; Kessler H; Schwaiger M
    Theranostics; 2015; 5(6):618-30. PubMed ID: 25825601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.
    Lapa C; Lückerath K; Rudelius M; Schmid JS; Schoene A; Schirbel A; Samnick S; Pelzer T; Buck AK; Kropf S; Wester HJ; Herrmann K
    Oncotarget; 2016 Feb; 7(8):9288-95. PubMed ID: 26843617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach.
    Werner RA; Weich A; Higuchi T; Schmid JS; Schirbel A; Lassmann M; Wild V; Rudelius M; Kudlich T; Herrmann K; Scheurlen M; Buck AK; Kropf S; Wester HJ; Lapa C
    Theranostics; 2017; 7(6):1489-1498. PubMed ID: 28529632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on
    Xu L; Tetteh G; Lipkova J; Zhao Y; Li H; Christ P; Piraud M; Buck A; Shi K; Menze BH
    Contrast Media Mol Imaging; 2018; 2018():2391925. PubMed ID: 29531504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemokine receptor-4 targeted PET/CT with
    Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Wei X; Wu F; Dong H; Jing Y; Song Y; Pang H; Chen J; Du Z; He W; Ma L; Wang Y; Hu J; Li Q; Yang S;
    Endocrine; 2024 Sep; 85(3):1398-1406. PubMed ID: 38914747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CXCR4-Targeted 68 Ga-Pentixafor PET/CT Imaging in Inflammatory Bowel Disease.
    Chen Y; Yuan H; Tan X; Shang Y; Sun X; Wang P; Jiang L
    Clin Nucl Med; 2024 Sep; 49(9):817-821. PubMed ID: 39086048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.
    Mayerhoefer ME; Jaeger U; Staber P; Raderer M; Wadsak W; Pfaff S; Kornauth C; Senn D; Weber M; Wester HJ; Skrabs C; Haug A
    Invest Radiol; 2018 Jul; 53(7):403-408. PubMed ID: 29642081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CXCR4-targeted theranostics in oncology.
    Buck AK; Serfling SE; Lindner T; Hänscheid H; Schirbel A; Hahner S; Fassnacht M; Einsele H; Werner RA
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4133-4144. PubMed ID: 35674738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT.
    Kuyumcu S; Yilmaz E; Büyükkaya F; Özkan ZG; Ünal SN
    Clin Nucl Med; 2018 Aug; 43(8):606-608. PubMed ID: 29916918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI.
    Starzer AM; Berghoff AS; Traub-Weidinger T; Haug AR; Widhalm G; Hacker M; Rausch I; Preusser M; Mayerhoefer ME
    Clin Nucl Med; 2021 Jan; 46(1):16-20. PubMed ID: 33208624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.
    Hartlapp I; Hartrampf PE; Serfling SE; Wild V; Weich A; Rasche L; Roth S; Rosenwald A; Mihatsch PW; Hendricks A; Wiegering A; Wiegering V; Hänscheid H; Schirbel A; Werner RA; Buck AK; Wester HJ; Einsele H; Kunzmann V; Lapa C; Kortüm KM
    J Nucl Med; 2023 Sep; 64(9):1424-1430. PubMed ID: 37348915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism.
    Zheng Y; Long T; Peng N; Zhen M; Ye Q; Zhang Z; He Y; Chen Z; Gan Y; Luo M; Li C; Liu Z; Guo M; Wang M; Luo X; Hu S; Liu L; Jiang T
    J Clin Endocrinol Metab; 2023 Dec; 109(1):171-182. PubMed ID: 37477496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of 68 Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome.
    Ding J; Tong A; Hacker M; Feng M; Huo L; Li X
    Clin Nucl Med; 2022 Aug; 47(8):669-676. PubMed ID: 35452014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.